Tianjin, China

Lina Wang

This inventor holds 4 USPTO granted patents. Top assignee: Andon Health Co., Ltd.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lina Wang. Retrieved from https://idiyas.com/inventor/lina-wang-i08desz2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lina Wang: Innovator in Health Technology

Introduction

Lina Wang is a prominent inventor based in Tianjin, China. She has made significant contributions to the field of health technology, particularly in the development of medical devices. With a total of 4 patents to her name, she has established herself as a key figure in innovation.

Latest Patents

Among her latest inventions are a blood pressure measuring apparatus and a low-frequency therapy device. These innovations reflect her commitment to improving healthcare solutions and enhancing patient well-being.

Career Highlights

Lina Wang is currently employed at Andon Health Co., Ltd., a company known for its focus on health technology. Her work at Andon Health has allowed her to collaborate with other talented professionals in the industry.

Collaborations

Some of her notable coworkers include Zhiqing Liu and Chunpo Liu. Their collective expertise contributes to the advancement of innovative health solutions.

Conclusion

Lina Wang's contributions to health technology through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…